DYNATE: Localizing rare‐variant association regions via multiple testing embedded in an aggregation tree
Xuechan Li(Duke University), Jichun Xie(University of Minnesota), Kouros Owzar(Duke University), Matthew Harms(Lourdes University), Andrew S. Allen(Duke University), Jianfeng Lu(Duke University), John Pura(AstraZeneca (United Kingdom))
Cited by 1
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655